News Headlines Article

High hopes for Alzheimer’s drug in clinical trials
San Francisco Chronicle

When an experimental Alzheimer’s drug recently showed impressive early-stage results, the company immediately planned large-scale trials, and the scientists behind it responded like weary optimists.

They’d been down this path before, only to see their hopes dashed when a drug aimed at the neurological disease failed in larger groups of patients.

This time they sense things could be different.